Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-07-08 4:57 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 799,341 2% | -1,616,006 (-66.91%) | View |
| 2022-02-14 3:02 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 3,468,944 8.8% | 376,726 (+12.18%) | View |
| 2022-02-11 4:54 pm Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | COLUMN GROUP II LP | 3,671,522 9.3% | -1,096,659 (-23.00%) | View |
| 2022-02-09 10:24 am Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 5,907,279 14.999% | 454,932 (+8.34%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 2,415,347 6.1% | 536,439 (+28.55%) | View |
| 2022-02-02 3:53 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | VICTORY CAPITAL MANAGEMENT INC | 2,301,232 5.84% | 2,301,232 (New Position) | View |
| 2021-08-12 4:17 pm Sale | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,212,571 5.6% | -254,721 (-10.32%) | View |
| 2021-03-19 6:06 pm Sale | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,467,292 6.8% | -298,425 (-10.79%) | View |
| 2021-02-16 12:07 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 3,092,218 8.7% | 450,000 (+17.03%) | View |
| 2021-02-12 6:24 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | COLUMN GROUP II LP | 4,768,181 13.1% | 4,768,181 (New Position) | View |
| 2021-02-08 10:29 am Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 5,452,347 14.999% | 2,215,014 (+68.42%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | BlackRock Inc. BLK | 1,878,908 5.3% | 1,878,908 (New Position) | View |
| 2020-11-18 2:42 pm Unchanged | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,765,717 7.8% | 0 (Unchanged) | View |
| 2020-11-05 08:53 am Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | Topspin Fund L.P. | 1,100,446 3.67% | -2,212,178 (-66.78%) | View |
| 2020-05-11 08:45 am Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | FMR LLC | 3,237,333 10.82% | 3,237,333 (New Position) | View |
| 2020-05-01 5:29 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | EcoR1 Capital LLC | 2,642,218 8.8% | 2,642,218 (New Position) | View |
| 2020-05-01 4:15 pm Purchase | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,765,717 9.2% | 2,765,717 (New Position) | View |
| 2020-04-28 7:51 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Topspin Fund L.P. | 3,312,624 11.51% | 3,312,624 (New Position) | View |